Skip to main content
. 2012 Mar 19;7:10. doi: 10.1186/1747-597X-7-10

Table 1.

Comparison of subjects with and without criminal charges in the 2 years after initiation of office-based buprenorphine treatment

Characteristic Criminal charges (N = 97) No criminal charges (N = 155) Χ2, df P-valuea
Median Age (range) 40 (20-56) 41 (18-67) 0.770b

Sex
 Male 56 (57.7%) 86 (55.5%) 0.12, 1 0.726
 Female 41 (42.3%) 69 (44.5%)

Insurance
 Commercial 38 (39.2%) 66 (42.6%) 0.29, 1 0.593
 Medicaid 36 (37.1%) 53 (34.2%) 0.22, 1 0.637
 Medicare 19 (19.6%) 23 (14.8%) 0.04, 1 0.839
 None 4 (4.1%) 4 (2.6%) 0.46, 1 0.497

Employment Status
 Employed 38 (39.2%) 75 (48.4%) 2.07, 1 0.153
 Unemployed 31 (32.0%) 43 (27.7%) 0.51, 1 0.457
 Disabled 28 (28.9%) 37 (23.9%) 0.78, 1 0.378

Abused Substances
 Heroin 90 (92.8%) 119 (76.8%) 10.81, 1 0.001
 Opioid Rx 15 (15.5%) 57 (36.8%) 13.28, 1 < 0.001
 Cocaine 58 (59.8%) 76 (49.0%) 0.003, 1 0.096
 Alcohol 16 (16.5%) 26 (16.8%) 2.78,1 0.954
 Benzodiazepines 8 (8.2%) 15 (9.7%) 0.15, 1 0.701

Recent opioid maintenance treatment 18 (18.6%) 50 (32.3%) 5.69, 1 0.017

IDU 67 (69.1%) 85 (54.8%) 5.05, 1 0.025

Co-morbidities
 HIV 14 (14.4%) 22 (14.2%) 0.003, 1 0.958
 HCV 58 (59.8%) 67 (43.2%) 6.55, 1 0.010
 Psychiatric 102 (51.3%) 23 (43.4%) 1.60, 1 0.309
 Chronic Pain 35 (17.6%) 11 (20.8%) 0.82, 1 0.596

Any prior criminal charges 97 (100%) 105 (67.7%) 39.04, 1 < 0.001

Median number of prior criminal cases (range) 9 (1-43) 1 (0-25) < 0.001b

Any criminal charges in past 2 years 62 (63.9%) 46 (29.7%) 28.56, 1 < 0.001

≥ 6 opioid-negative mos. 34 (35.1%) 83 (53.5%) 8.21, 1 0.004

12 mos. in treatment 46 (47.4%) 93 (60.0%) 3.82, 1 0.051

IDU: injection drug use, HCV: hepatitis C infection, HIV: human immunodeficiency virus infection, df: degrees of freedom

a Pearson chi-square test unless otherwise indicated; b Mann Whitney U test